Surgical management of hip osteoarthritis

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 5, 2014, Pages 347-355

  Gandhi, Rajiv ^a   Perruccio, Anthony V ^b   Mahomed, Nizar N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIC PROSTHESIS; CLINICAL FEATURE; DEVICE INFECTION; DIABETES MELLITUS; GLYCEMIC CONTROL; HIP OSTEOARTHRITIS; HIP PROSTHESIS; HIP SURGERY; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; METAL IMPLANTATION; METAL ON METAL IMPLANT; ORTHOPEDIC EQUIPMENT; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT REFERRAL; PATIENT SELECTION; PROSTHESIS LOOSENING; RECURRENT DISLOCATION; REOPERATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SELF REPORT; SOCIAL ASPECT; SURGICAL APPROACH; SURGICAL INFECTION; TISSUE ENGINEERING; TREATMENT INDICATION; TREATMENT RESPONSE;

ARTHROPLASTY, REPLACEMENT, HIP; HIP JOINT; HUMANS; OSTEOARTHRITIS, HIP; OSTEOTOMY; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84896527236     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.121584     Document Type: Review

References (103)

1. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006;20:3-25.
2. Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004;42:1-9.
3. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2008;34:515-29.
4. Methodological notes: Canadian Joint Replacement Registry quick stats, September 2010, 2008-2009 data; overview of hip and knee replacements. Ottawa (ON): Canadian Institute for Health Information; 2010.
5. Dougados M, Hochberg MC. Management of osteoarthritis. In: Hochberg MC, Silman AJ, Smolen JS, et al. editors. Rheumatology. Philadelphia (PA): Mosby/Elsevier; 2011:1793-9.
6. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:465-74.
7. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669-81.
8. Fortin PR, Clarke AE, Joseph L, et al. Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum 1999;42:1722-8.
9. Garbuz DS, Xu M, Duncan CP, et al. Delays worsen quality of life outcome of primary total hip arthroplasty. Clin Orthop Relat Res 2006;447:79-84.
10. Vergara I, Bilbao A, Gonzalez N, et al. Factors and consequences of waiting times for total hip arthroplasty. Clin Orthop Relat Res 2011;469:1413-20.
11. Hajat S, Fitzpatrick R, Morris R, et al. Does waiting for total hip replacement matter? Prospective cohort study. J Health Serv Res Policy 2002;7:19-25.
12. Fortin PR, Penrod JR, Clarke AE, et al. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002;46:3327-30.
13. Lingard EA, Katz JN, Wright EA, et al. Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am 2004;86-A:2179-86.
14. Nilsdotter AK, Petersson IF, Roos EM, et al. Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study. Ann Rheum Dis 2003;62:923-30.
15. Röder C, Staub LP, Eggli S, et al. Influence of preoperative functional status on outcome after total hip arthroplasty. J Bone Joint Surg Am 2007;89:11-7.
16. Ethgen O, Bruyere O, Richy F, et al. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004;86-A:963-74.
17. Jones CA, Beaupre LA, Johnston DW, et al. Total joint arthroplasties: current concepts of patient outcomes after surgery. Rheum Dis Clin North Am 2007;33:71-86.
18. Santaguida PL, Hawker GA, Hudak PL, et al. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Can J Surg 2008;51:428-36.
19. Pedersen AB, Mehnert F, Johnsen S P, et al. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br 2010;92:929-34.
20. Møller AM, Villebro N, Pedersen T, et al. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359:114-7.
21. Steele MJ, Fox JS, Fletcher JP, et al. Clopidogrel dilemma for orthopaedic surgeons. ANZ J Surg 2011;81:774-84.
22. Luckie M, Khattar RS, Fraser D. Non-cardiac surgery and antiplatelet therapy following coronary artery stenting. Heart 2009;95:1303-8.
23. Hip and knee replacements in Canada - Canadian Joint Replacement Registry 2008-2009 annual report. Ottawa (ON): Canadian Institute for Health Information; 2009.
24. Corten K, Bourne RB, Charron KD, et al. What works best, a cemented or cementless primary total hip arthroplasty?: minimum 17-year followup of a randomized controlled trial. Clin Orthop Relat Res 2011;469:209-17.
25. Mäkelä KT, Eskelinen A, Pulkkinen P, et al. Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg Am 2008;90:2160-70.
26. Rothman RH, Cohn JC. Cemented versus cementless total hip arthroplasty. A critical review. Clin Orthop Relat Res 1990; (254): 153-69.
27. Maloney WJ. National joint replacement registries: Has the time come? J Bone Joint Surg Am 2001;83-A:1582-5.
28. Bunker J P, Frazier HS, Mosteller F. Improving health: measuring effects of medical care. Milbank Q 1994;72:225-58.
29. Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996;275:858-65.
30. Davis AM, Perruccio AV, Ibrahim S, et al. The trajectory of recovery and the inter-relationships of symptoms, activity and participation in the first year following total hip and knee replacement. Osteoarthritis Cartilage 2011;19:1413-21.
31. Gandhi R, Dhotar H, Davey JR, et al. Predicting the longer-term outcomes of total hip replacement. J Rheumatol 2010;37:2573-7.
32. Jones CA, Voaklander DC, Johnston DW, et al. Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol 2000;27:1745-52.
33. Mancuso CA, Salvati EA, Johanson NA, et al. Patients' expectations and satisfaction with total hip arthroplasty. J Arthroplasty 1997;12:387-96.
34. Perruccio AV, Davis AM, Hogg-Johnson S, et al. The importance of self-rated health and mental well-being in predicting health outcomes following total joint replacement surgery for osteoarthritis. Arthritis Care Res (Hoboken) 2011;63:973-81.
35. Mahomed NN, Barrett JA, Katz JN, et al. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am 2003;85-A:27-32.
36. Corbett KL, Losina E, Nti AA, et al. Population-based rates of revision of primary total hip arthroplasty: a systematic review. PLoS ONE 2010;5:e13520.
37. NHS 2010-2015: from good to great. Preventative, people-centred, productive. London (UK): Department of Health; 2009:30-2.
38. Levy RN, Levy CM, Snyder J, et al. Outcome and long-term results following total hip replacement in elderly patients. Clin Orthop Relat Res 1995; (316): 25-30.
39. Anakwe RE, Jenkins PJ, Moran M. Predicting dissatisfaction after total hip arthroplasty: a study of 850 patients. J Arthroplasty 2011;26:209-13.
40. Hulleberg G, Aamodt A, Espehaug B, et al. A clinical and radiographic 13-year follow-up study of 138 Charnley hip arthroplasties in patients 50-70 years old: comparison of university hospital data and registry data. Acta Orthop 2008;79:609-17.
41. Rolfson O, Dahlberg LE, Nilsson JA, et al. Variables determining outcome in total hip replacement surgery. J Bone Joint Surg Br 2009;91:157-61.
42. Rolfson O, Karrholm J, Dahlberg LE, et al. Patient-reported outcomes in the Swedish Hip Arthroplasty Register: results of a nationwide prospective observational study. J Bone Joint Surg Br 2011;93:867-75.
43. Baumann C, Rat AC, Osnowycz G, et al. Do clinical presentation and preoperative quality of life predict satisfaction with care after total hip or knee replacement? J Bone Joint Surg Br 2006;88:366-73.
44. Amstutz HC, Le Duff MJ, Campbell PA, et al. Complications after metal-on-metal hip resurfacing arthroplasty. Orthop Clin North Am 2011;42:207-30.
45. Kwon YM, Glyn-Jones S, Simpson DJ, et al. Analysis of wear of retrieved metal-on-metal hip resurfacing implants revised due to pseudotumours. J Bone Joint Surg Br 2010;92:356-61.
46. Macpherson GJ, Breusch SJ. Metal-on-metal hip resurfacing: a critical review. Arch Orthop Trauma Surg 2011;131:101-10.
47. Shimmin A, Beaule PE, Campbell P. Metal-on-metal hip resurfacing arthroplasty. J Bone Joint Surg Am 2008;90:637-54.
48. Smith AJ, Dieppe P, Howard PW, et al. Failure rates of metal-onmetal hip resurfacings: analysis of data from the National Joint Registry for England and Wales. Lancet 2012;380:1759-66.
49. Smith TO, Nichols R, Donell ST, et al. The clinical and radiological outcomes of hip resurfacing versus total hip arthroplasty: a meta-analysis and systematic review. Acta Orthop 2010;81:684-95.
50. Amstutz HC, Ball ST, Le Duff MJ, et al. Resurfacing THA for patients younger than 50 year: results of 2-to 9-year followup. Clin Orthop Relat Res 2007;460:159-64.
51. Heilpern GN, Shah NN, Fordyce MJ. Birmingham hip resurfacing arthroplasty: a series of 110 consecutive hips with a minimum five-year clinical and radiological follow-up. J Bone Joint Surg Br 2008;90:1137-42.
52. Hing CB, Back DL, Bailey M, et al. The results of primary Birmingham hip resurfacings at a mean of five years. An independent prospective review of the first 230 hips. J Bone Joint Surg Br 2007;89:1431-8.
53. Steffen RT, Pandit HP, Palan J, et al. The five-year results of the Birmingham Hip Resurfacing arthroplasty: an independent series. J Bone Joint Surg Br 2008;90:436-41.
54. Baker RP, Pollard TC, Eastaugh-Waring SJ, et al. A medium-term comparison of hybrid hip replacement and Birmingham hip resurfacing in active young patients. J Bone Joint Surg Br 2011;93:158-63.
55. Mont MA, Marker DR, Smith JM, et al. Resurfacing is comparable to total hip arthroplasty at short-term follow-up. Clin Orthop Relat Res 2009;467:66-71.
56. Pollard TC, Baker RP, Eastaugh-Waring SJ, et al. Treatment of the young active patient with osteoarthritis of the hip. A five-to seven-year comparison of hybrid total hip arthroplasty and metal-on-metal resurfacing. J Bone Joint Surg Br 2006;88:592-600.
57. Stulberg BN, Fitts SM, Bowen AR, et al. Early return to function after hip resurfacing: Is it better than contemporary total hip arthroplasty? J Arthroplasty 2010;25:748-53.
58. Vail T P, Mina CA, Yergler JD, et al. Metal-on-metal hip resurfacing compares favorably with THA at 2 years followup. Clin Orthop Relat Res 2006; (453): 123-31.
59. Vendittoli PA, Ganapathi M, Roy AG, et al. A comparison of clinical results of hip resurfacing arthroplasty and 28 mm metal on metal total hip arthroplasty: a randomised trial with 3-6 years follow-up. Hip Int 2010;20:1-13.
60. Beaulé PE, Dorey FJ, Le Duff MJ, et al. Risk factors affecting outcome of metal-on-metal surface arthroplasty of the hip. Clin Orthop Relat Res 2004; (418): 87-93.
61. Hart AJ, Buddhdev P, Winship P, et al. Cup inclination angle of greater than 50 degrees increases whole blood concentrations of cobalt and chromium ions after metal-on-metal hip resurfacing. Hip Int 2008;18:212-9.
62. Treacy RB, McBryde CW, Shears E, et al. Birmingham hip resurfacing: a minimum follow-up of ten years. J Bone Joint Surg Br 2011;93:27-33.
63. O'Neill M, Beaule PE, Bin NA, et al. Canadian academic experience with metal-on-metal hip resurfacing. Bull NYU Hosp Jt Dis 2009;67:128-31.
64. Amstutz HC, Campbell PA, Le Duff MJ. Fracture of the neck of the femur after surface arthroplasty of the hip. J Bone Joint Surg Am 2004;86-A:1874-7.
65. Siebel T, Maubach S, Morlock MM. Lessons learned from early clinical experience and results of 300 ASR hip resurfacing implantations. Proc Inst Mech Eng H 2006;220:345-53.
66. Van Der Weegen W, Hoekstra HJ, Sijbesma T, et al. Survival of metal-on-metal hip resurfacing arthroplasty: a systematic review of the literature. J Bone Joint Surg Br 2011;93:298-306.
67. Heneghan C, Langton D, Thompson M. Ongoing problems with metal-on-metal hip implants. BMJ 2012;344:e1349.
68. Mont MA, Seyler TM, Ulrich SD, et al. Effect of changing indications and techniques on total hip resurfacing. Clin Orthop Relat Res 2007;465:63-70.
69. Prosser GH, Yates PJ, Wood DJ, et al. Outcome of primary resurfacing hip replacement: evaluation of risk factors for early revision. Acta Orthop 2010;81:66-71.
70. Garbuz DS, Tanzer M, Greidanus NV, et al. The John Charnley Award: Metal-on-metal hip resurfacing versus large-diameter head metal-on-metal total hip arthroplasty: a randomized clinical trial. Clin Orthop Relat Res 2010;468:318-25.
71. Lavigne M, Therrien M, Nantel J, et al. The John Charnley Award: The functional outcome of hip resurfacing and largehead THA is the same: a randomized, double-blind study. Clin Orthop Relat Res 2010;468:326-36.
72. Corten K, MacDonald SJ. Hip resurfacing data from national joint registries: What do they tell us? What do they not tell us? Clin Orthop Relat Res 2010;468:351-7.
73. Johanson PE, Fenstad AM, Furnes O, et al. Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty. Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007. Acta Orthop 2010;81:535-41.
74. Costa ML, Achten J, Parsons NR, et al. Total hip arthroplasty versus resurfacing arthroplasty in the treatment of patients with arthritis of the hip joint: single centre, parallel group, assessor blinded, randomised controlled trial. BMJ 2012;344:e2147.
75. Lavigne M, Masse V, Girard J, et al. [Return to sport after hip resurfacing or total hip arthroplasty: a randomized study] [article in French]. Rev Chir Orthop Reparatrice Appar Mot 2008;94:361-7.
76. Jolles BM, Bogoch ER. Posterior versus lateral surgical ap - proach for total hip arthroplasty in adults with osteoarthritis. Cochrane Database Syst Rev 2006; (3): CD003828.
77. Ogonda L, Wilson R, Archbold P, et al. A minimal-incision technique in total hip arthroplasty does not improve early postoperative outcomes. A prospective, randomized, controlled trial. J Bone Joint Surg Am 2005;87:701-10.
78. Sculco TP, Jordan LC, Walter WL. Minimally invasive total hip arthroplasty: the Hospital for Special Surgery experience. Orthop Clin North Am 2004;35:137-42.
79. Chimento GF, Pavone V, Sharrock N, et al. Minimally invasive total hip arthroplasty: a prospective randomized study. J Arthroplasty 2005;20:139-44.
80. Dorr LD, Maheshwari AV, Long WT, et al. Early pain relief and function after posterior minimally invasive and conventional total hip arthroplasty. A prospective, randomized, blinded study. J Bone Joint Surg Am 2007;89:1153-60.
81. Reininga IH, Zijlstra W, Wagenmakers R, et al. Minimally invasive and computer-navigated total hip arthroplasty: a qualitative and systematic review of the literature. BMC Musculoskelet Disord 2010;11:92.
82. Lewis PM, Al-Belooshi A, Olsen M, et al. Prospective randomized trial comparing alumina ceramic-on-ceramic with ceramicon-conventional polyethylene bearings in total hip arthroplasty. J Arthroplasty 2010;25:392-7.
83. Qu X, Huang X, Dai K. Metal-on-metal or metal-on-polyethylene for total hip arthroplasty: a meta-analysis of prospective randomized studies. Arch Orthop Trauma Surg 2011;131:1573-83.
84. Dahlstrand H, Stark A, Anissian L, et al. Elevated serum concentrations of cobalt, chromium, nickel, and manganese after metalon-metal alloarthroplasty of the hip: a prospective randomized study. J Arthroplasty 2009;24:837-45.
85. Engh CA Jr, MacDonald SJ, Sritulanondha S, et al. 2008 John Charnley award: metal ion levels after metal-on-metal total hip arthroplasty: a randomized trial. Clin Orthop Relat Res 2009;467:101-11.
86. Lombardi AV Jr, Mallory TH, Cuckler JM, et al. Mid-term results of a polyethylene-free metal-on-metal articulation. J Arthroplasty 2004;19(Suppl 2):42-7.
87. MacDonald SJ, McCalden RW, Chess DG, et al. Metal-on-metal versus polyethylene in hip arthroplasty: a randomized clinical trial. Clin Orthop Relat Res 2003;406:282-96.
88. Zijlstra WP, Van Raay JJ, Bulstra SK, et al. No superiority of cemented metal-on-metal over metal-on-polyethylene THA in a randomized controlled trial at 10-year follow-up. Orthopedics 2010;33(3). doi: 10.3928/01477447-20100129-19
89. Smith AJ, Dieppe P, Vernon K, et al. Failure rates of stemmed metal-on-metal hip replacements: analysis of data from the National Joint Registry of England and Wales. Lancet 2012;379:1199-204.
90. Pandit H, Glyn-Jones S, Lardy-Smith P, et al. Pseudotumours associated with metal-on-metal hip resurfacings. J Bone Joint Surg Br 2008;90:847-51.
91. Frustaci A, Magnavita N, Chimenti C, et al. Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. J Am Coll Cardiol 1999;33:1578-83.
92. Mao X, Wong AA, Crawford RW. Cobalt toxicity - An emerging clinical problem in patients with metal-on-metal hip prostheses? Med J Aust 2011;194:649-51.
93. Tower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am 2010;92:2847-51.
94. Fabi D, Levine B, Paprosky W, et al. Metal-on-metal total hip arthroplasty: causes and high incidence of early failure. Orthopedics 2012;35:e1009-16.
95. Important safety information for orthopaedic surgeons regarding patient management following metal-on-metal implant surgery. Ottawa (ON): Health Canada; 2012.
96. US Food and Drug Administration. Medical devices: recalls. Washington (DC): US Department of Health and Human Services; 2012. Available: www.fda.gov/MedicalDevices/Products and MedicalProcedures/ ImplantsandProsthetics/MetalonMetal Hip Implants/ucm241770.htm (accessed 2013 Oct. 15).
97. Koo KH, Ha YC, Jung WH, et al. Isolated fracture of the ceramic head after third-generation alumina-on-alumina total hip arthroplasty. J Bone Joint Surg Am 2008;90:329-36.
98. Jarrett CA, Ranawat AS, Bruzzone M, et al. The squeaking hip: a phenomenon of ceramic-on-ceramic total hip arthroplasty. J Bone Joint Surg Am 2009;91:1344-9.
99. Lübbeke A, Katz JN, Perneger T V, et al. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol 2007;34:394-400.
100. Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009;91:128-33.
101. Suter LG, Paltiel AD, Rome BN, et al. Medical device innovation - Is "better" good enough? N Engl J Med 2011;365:1464-6.
102. Minas T, Gomoll AH, Solhpour S, et al. Autologous chondrocyte implantation for joint preservation in patients with early osteoarthritis. Clin Orthop Relat Res 2010;468:147-57.
103. Punwar S, Khan WS. Mesenchymal stem cells and articular cartilage repair: clinical studies and future direction. Open Orthop J 2011;5(Suppl 2):296-301.